Pacira BioSciences Reports First Quarter 2025 Financial Results

-- Conference call today at 4:30 p.m. ET --

BRISBANE, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today reported financial results for the first quarter of 2025.

Read more at globenewswire.com